Skip to content

EPRX

Eupraxia Pharmaceuticals, Inc.

NASDAQ · Healthcare · Biotechnology · CA

$6.95
+4.98%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 3, 2026
EPS estimate
-$0.26
Revenue estimate
—

Latest reported

Last report date
Aug 11, 2026
EPS actual
-$0.23
EPS estimate
-$0.25
Revenue actual
—
Revenue estimate
—

Track record

Trailing twelve quarters

EPS beats (12Q)
2
EPS misses (12Q)
4
EPS in line (12Q)
0
Avg surprise (4Q)
-9.3%
Revenue beats (12Q)
—

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$14
PT range
$11 – $17
Analysts
2
2 Buy0 Hold0 Sell
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 11, 2026-$0.25-$0.23Beat 8.00%—
May 12, 2026-$0.22-$0.23Miss -4.55%—
Aug 12, 2025-$0.21-$0.26Miss -23.81%—
Mar 20, 2025-$0.18-$0.21Miss -16.67%—
Nov 7, 2024-$0.13-$0.17Miss -30.05%—
Mar 21, 2024—-$0.15—$3.0M
Sep 29, 2022-$0.31-$0.22Beat 29.96%—

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026